Pulse Biosciences Inc PLSE 深 滬
已收盤 09-05 16:00:00 美东时间
15.11
-0.060
-0.40%
華盛通- 最 高15.42
- 今 開15.17
- 成交量 7.17万股
- 最 低 14.94
- 昨 收 15.17
- 總市值 10.17亿
- 52周最高 25.00
- 市盈率 靜 --
- 換手率 0.11%
- 52周最低 13.7658
- 委 比 74.26%
- 總股本 6727.39万
- 歷史最高 45.82
- 量 比 0.58
- 振 幅 3.16%
- 歷史最低 1.18
- 每 手 1
- 風險率 1.76%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Pulse Biosciences Begins First Study Using Nanosecond PFA Tech To Treat Benign Thyroid Nodules
Pulse Biosciences, Inc. (NASDAQ:PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nanosecond PFA or nsPFA™) technology, today announced the first successful procedures
09-02 19:05
Pulse Biosciences Announced A New Publication In The Journal Thyroid, The First-in-human Clinical Feasibility Study Demonstrates The Effectiveness Of Ablation Of Benign Thyroid Nodules Using Nanosecond Pulsed Field Ablation (nsPFA) Energy
The study was designed to assess the ability of nsPFA energy to provide a safe and effective option for the treatment of symptomatic benign thyroid nodules with minimal side effects. The study was conducted by Professor
08-26 19:05
Pulse Biosciences shares are trading lower after the company reported a Q2 EPS miss.
Pulse Biosciences shares are trading lower after the company reported a Q2 EPS ...
08-13 22:30
Pulse Biosciences Q2 EPS $(0.28) Misses $(0.26) Estimate
Pulse Biosciences (NASDAQ:PLSE) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.26) by 7.69 percent. This is a 40 percent decrease over losses of $(0.20) per share from
08-13 04:11
Earnings Scheduled For August 12, 2025
Companies Reporting Before The Bell • Smithfield Foods (NASDAQ:SFD) is expected...
08-12 16:32
Pulse Biosciences Appoints New VP of Accounting
The latest announcement is out from Pulse Biosciences ( ($PLSE) ). Pulse Biosci...
07-15 05:20
美股大行评级 | 潜在涨幅199.47%！杰富瑞上调Cogent Biosciences目标价至28美元，维持"买入"评级
今日重点评级关注：杰富瑞：维持Cogent Biosciences"买入"评级，目标价从23美元升至28美元；Leerink Partners：维持Cogent Biosciences"跑赢大市"评级，目标价从16美元升至18美元
07-08 09:34
Oppenheimer Initiates Coverage On Pulse Biosciences with Outperform Rating, Announces Price Target of $22
Oppenheimer analyst Suraj Kalia initiates coverage on Pulse Biosciences (NASDAQ:PLSE) with a Outperform rating and announces Price Target of $22.
07-07 21:50
Pulse Biosciences Earnings Call: Progress and Challenges
Pulse Biosciences Inc (($PLSE)) has held its Q1 earnings call. Read on for the ...
05-13 08:51
Earnings Scheduled For May 8, 2025
Companies Reporting Before The Bell • Sempra (NYSE:SRE) is likely to report qua...
05-08 16:33
